Invasive pulmonary aspergillosis in patients with HBV-related liver failure

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 30, Issue 5, 2011, Pages 661-667

  Wang, W ^a   Zhao, C Y ^a   Zhou, J Y ^a   Wang, Y D ^a   Shen, C ^a   Zhou, D F ^a   Yin, H Z ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; STEROID;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CLINICAL FEATURE; CONTROLLED STUDY; COUGHING; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG USE; FEMALE; FEVER; HEMOPTYSIS; HEPATITIS B; HUMAN; INVASIVE PROCEDURE; LIVER FAILURE; LUNG ASPERGILLOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; STEROID THERAPY; SURVIVAL RATE; SURVIVAL TIME; THORAX PAIN;

ADULT; CASE-CONTROL STUDIES; FEMALE; HEPATITIS B, CHRONIC; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS; LIVER FAILURE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 79956061730     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-010-1137-2     Document Type: Article

References (19)

1. Liu Q, Liu Z, Wang T et al (2008) Characteristics of acute and sub-acute liver failure in China: nomination, classification and interval. J Gastroenterol Hepatol 22:2101-2106 (Pubitemid 350145590)
2. Li D, Chen L, Ding X et al (2008) Hospital-acquired invasive pulmonary aspergillosis in patients with hepatic failure. BMC Gastroenterol 8:32
3. Rolando N, Wade J, Davalos M et al (2000) The systemic inflammatory response syndrome in acute liver failure. Hepatology 32:734-739
4. Segal BH (2009) Aspergillosis. N Engl J Med 360:1870-1884
5. Herbrecht R, Natarajan-Ame S, Letscher-Bru V et al (2004) Invasive pulmonary aspergillosis. Semin Respir Crit Care Med 25:191-202 (Pubitemid 38552370)
6. Hardak E, Yigla M, Avivi I et al (2009) Impact of PCR-based diagnosis of invasive pulmonary aspergillosis on clinical outcome. Bone Marrow Transplant 44:595-599
7. Maschmeyer G, Haas A, Cornely OA (2007) Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients. Drugs 67:1567-1601 (Pubitemid 47267298)
8. Meersseman W, Lagrou K, Maertens J et al (2007) Invasive aspergillosis in the intensive care unit. Clin Infect Dis 45:205-216 (Pubitemid 47044802)
9. Prodanovic H, Cracco C, Massard J et al (2007) Invasive pulmonary aspergillosis in patients with decompensated cirrhosis: case series. BMC Gastroenterol 7:2
10. Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Diseases and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association (2006) Diagnostic and treatment guidelines for liver failure [in Chinese]. Zhonghua Gan Zang Bing Za Zhi 14:643-646
11. De Pauw B, Walsh TJ, Donnelly JP et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813-1821
12. Pasqualotto AC (2009) Differences in pathogenicity and clinical syndromes due to Aspergillus fumigatus and Aspergillus flavus. Med Mycol 47(Suppl 1):S261-S270
13. Cheruvattath R, Balan V (2007) Infections in patients with endstage liver disease. J Clin Gastroenterol 41:403-411 (Pubitemid 46573071)
14. Marik PE (2006) Fungal infections in solid organ transplantation. Expert Opin Pharmacother 7:297-305
15. Greene RE, Schlamm HT, Oestmann JW et al (2007) Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis 44:373-379 (Pubitemid 46147619)
16. Singh N, Wagener MM, Cacciarelli TV et al (2008) Antifungal management practices in liver transplant recipients. Am J Transplant 8:426-431
17. Wagner C, Graninger W, Presterl E et al (2006) The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applications. Pharmacology 78:161-177 (Pubitemid 44948055)
18. Walsh TJ, Pappas P, Winston DJ et al (2002) Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med 346:225-234 (Pubitemid 34438861)
19. Herbrecht R, Denning DW, Patterson TF et al (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347:408-415 (Pubitemid 34851833)